Liquidia (LQDA) Change in Receivables (2021 - 2026)
Liquidia (LQDA) posted quarterly Change in Receivables of $20.1 million for Q1 2026, up 1463.04% year-over-year from $1.3 million in Q1 2025, and up 10.64% quarter-over-quarter from $18.1 million in Q4 2025.
Liquidia (LQDA) Change in Receivables (2021 - 2026) Analysis & Trends
Liquidia's Change in Receivables history runs 6 years deep, the most recent figure standing at $20.1 million for Q1 2026.
- In Q1 2026, Change in Receivables rose 1463.04% year-over-year to $20.1 million; the TTM figure through Mar 2026 stood at $72.9 million (up 5610.96% YoY), while the FY2025 annual figure was $51.4 million, up 3928.17% from the prior year.
- Change in Receivables for Q1 2026 stood at $20.1 million, up from $18.1 million in the prior quarter.
- The five-year high for Change in Receivables was $26.0 million in Q3 2025, with the low at -$1.5 million in Q1 2024.
- The 5-year median for Change in Receivables is $466000.0 (2022), against an average of $4.2 million.
- Peak annual rise in Change in Receivables reached 3235.0% in 2022, while the deepest fall reached 1163.79% in 2022.
- Liquidia's Change in Receivables stood at $1.9 million in 2022, then sank by 61.56% to $723000.0 in 2023, then slumped by 305.12% to -$1.5 million in 2024, then soared by 1322.79% to $18.1 million in 2025, then rose by 10.64% to $20.1 million in 2026.
- Business Quant data shows LQDA's Change in Receivables at $20.1 million in Q1 2026, $18.1 million in Q4 2025, and $26.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Liquidia | 6.40 Bn | 6.11 Bn | 160.92 Mn | 34.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.43 Mn |
| Jun 30, 2026 | 34.43 Mn |
| Mar 31, 2026 | 20.06 Mn |
| Mar 31, 2026 | 20.06 Mn |
| Dec 31, 2025 | 18.13 Mn |
| Dec 31, 2025 | 18.13 Mn |
| Sep 30, 2025 | 25.99 Mn |
| Sep 30, 2025 | 25.99 Mn |
| Jun 30, 2025 | 8.72 Mn |
| Jun 30, 2025 | 8.72 Mn |
| Mar 31, 2025 | -1.47 Mn |
| Mar 31, 2025 | -1.47 Mn |
| Dec 31, 2024 | -1.48 Mn |
| Dec 31, 2024 | -1.48 Mn |
| Sep 30, 2024 | 953,000.00 |
| Sep 30, 2024 | 953,000.00 |
| Jun 30, 2024 | 679,000.00 |
| Jun 30, 2024 | 679,000.00 |
| Mar 31, 2024 | -1.49 Mn |
| Mar 31, 2024 | -1.49 Mn |